Article Text
PDFMiscellaneous
Corrections
Statistics from Altmetric.com
Palace J, Leite MI, Jacob A. A practical guide …
Read the full text or download the PDF:
Other content recommended for you
- Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder
- Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Safety and efficacy of mycophenolate mofetil in treating neuromyelitis optica spectrum disorders: a protocol for systematic review and meta-analysis
- Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
- CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD
- Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
- Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
- Brain age gap in neuromyelitis optica spectrum disorders and multiple sclerosis
- Overlapping CNS inflammatory diseases: differentiating features of NMO and MS